| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.64 | 0.03 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.41 | 0.03 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.29 | 0.05 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0007 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-08 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.003 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |